Bette Caan to Polymerase Chain Reaction
This is a "connection" page, showing publications Bette Caan has written about Polymerase Chain Reaction.
Connection Strength
0.236
-
Genetic variation in the transforming growth factor-ß-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum. 2012 May; 55(5):532-40.
Score: 0.098
-
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013 Dec; 24(12):2059-75.
Score: 0.027
-
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
Score: 0.022
-
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog. 2009 Nov; 48(11):989-94.
Score: 0.021
-
Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009 Nov; 20(9):1763-8.
Score: 0.020
-
CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2752-5.
Score: 0.018
-
Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1350-2.
Score: 0.015
-
Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1206-14.
Score: 0.014